D-0079-2027 Class II Ongoing

Recalled by STRIDES PHARMA INC — Bridgewater, NJ

FDA drug recall D-0079-2027 was initiated by STRIDES PHARMA INC on Oct 7, 2026 and is designated Class II. Reason for recall: Failed dissolution specifications The recall status is ongoing. Affected quantity: 49,488 30-count bottles.

Recall Details

Product Type
Drugs
Report Date
Oct 28, 2026
Initiation Date
Oct 7, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
49,488 30-count bottles

Product Description

Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, 605 014, India; Distributed by: Strides Pharma Inc. Bridgewater, NJ 08807, NDC 64380-883-04

Reason for Recall

Failed dissolution specifications

Distribution Pattern

US Nationwide

Code Information

Lot # 7717825A, Expiry: 11/30/2028.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0079-2027
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0079-2027. Report a data issue: hello@regdatalab.com.